Physician profile
Amy S Wang
NPI 1265662290
$573.71
in general payments reported to CMS, 2019-2025
9 companies · $21.27 in 2025
The $21.27 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.54 · 2020: $107 · 2022: $41.16 · 2023: $114 · 2024: $279 · 2025: $21.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $162.56 | 2022-2024 | Fotivda |
| Abbott Laboratories | $123.94 | 2024 | Eterna |
| Edwards Lifesciences Corporation | $106.54 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $46.30 | 2019-2024 | Libtayo |
| Eisai INC. | $42.75 | 2024 | |
| Daiichi Sankyo INC. | $25.23 | 2024 | Enhertu |
| Incyte Corporation | $22.81 | 2023 | Jakafi |
| Beigene USA, INC. | $22.31 | 2022 | |
| Deciphera Pharmaceuticals INC. | $21.27 | 2025 | Romvimza, Qinlock |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.